FDA advisers will meet in May to discuss whether the agency should allow a birth control pill to be sold over the counter.
for allowing birth control pills to be sold over the counter, saying it could remove barriers and increase access to contraceptives.
Two FDA advisory committees — the Nonprescription Drugs Advisory Committee and the Reproductive and Urologic Drugs Advisory Committee — were initially scheduled to meet on Nov. 18, but the agency pushed back that date to"review additional information requested related to the Opill Rx-to-OTC switch," according toOpill is a progestin-only medication, also referred to as a"mini-pill." Progestin is a synthetic hormone that mimics the effects of progesterone in the body.
The push for prescription to over the counter comes amid legal battles regarding women's reproductive rights.the landmark Roe v. Wade ruling that guaranteed a constitutional right to abortion., one of two medications used in medication abortions.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA knew about latest baby formula problem months before recallFDA inspectors knew about contamination at the Enfamil plant in November, three months before the recall.
Lire la suite »
U.S. baby formula supply is still vulnerable, former FDA official tells lawmakersA former FDA official underscored dysfunction within the FDA that he believes exacerbated last year's nationwide infant formula shortage.
Lire la suite »
‘Lessons have not been learned’: FDA knew of positive test months before latest infant formula recallIn late February, formula giant Reckitt issued a press release recalling 145,000 cans of Enfamil ProSobee Simply Plant-Based Infant Formula over the “possibility of cross-contamination with Cronobacter sakazakii”
Lire la suite »
FDA Approves Pharming's Immune Disorder DrugThe US Food and Drug Administration on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.
Lire la suite »
FDA stonewalled abortion drug concerns to escape responsibility for their dangers[This is part three of a series on the first-of-its-kind federal lawsuit, Americans for Hippocratic Medicine v. U.S. Food and Drug Administration, in which doctors and medical practitioners are asking the courts to hold the FDA accountable for its reckless and illegal approval of dangerous chemical…
Lire la suite »
FDA Approves New Formulation of Hyrimoz Adalimumab BiosimilarThe agency approved a higher concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
Lire la suite »